WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines
An approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios
Overview
This revised roadmap (10 November 2023) replaces the previous version (30 March 2023).
It addresses evolving public health needs as the Omicron variant and its sub-lineages continue to circulate and provides updates for COVID-19 vaccination in relation to simplified vaccine schedules for programmatic use.
The Roadmap will be further adapted should new variants of concern emerge that do not have the characteristics of Omicron, or in the event of significant changes in COVID-19 disease epidemiology, or if significant changes in vaccine attributes warrant an update to the Roadmap.
This document has been updated: Version 10 November 2023.
Related document:
Archived versions:
- WHO SAGE roadmap on uses of COVID-19 vaccines in the context of OMICRON and substantial population immunity. Version 30 March 2023.
- WHO SAGE roadmap for prioritizing uses of COVID-19 vaccines. Version 21 January 2022
- Corrigenda for the WHO SAGE Roadmap for prioritizing uses of COVID-19 vaccines. Version 21 January 2022
- WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Version 16 July 2021
- WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Version 13 November 2020
- WHO SAGE Roadmap For Prioritizing Uses Of COVID-19 Vaccines In The Context Of Limited Supply. Version 20 October 2020
